Trial intelligence / Profile preview

YIC therapeutic hepatitis B vaccine dose-finding study in chronic hepatitis B

ChiCTR-TRC-07000022Phase 2Completed

Sponsor
National Vaccine and Serum Institute/Fudan University
Start
Sep 2005
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 2, randomised trial of YIC in Chronic Hepatitis B (CHB) (3 arms), sponsored by National Vaccine and Serum Institute/Fudan University. Primary endpoint: Virological response. Started Sep 2005; status: completed.

02

Drugs

YIC
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on ChiCTR-TRC-07000022.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-07000022.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call